Merus

Developer of antibody-based drugs for cancer treatment

placeUtrecht, Utrecht, Netherlands calendar_todayFounded 2003 groups221 employees language merus.nl

Registered entities

Social engagement

Social engagement: 17.3K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

17 investors on record.

Investor typeCountShare
Venture capital953%
Private equity318%
Other / undisclosed529%

Recent activity

11 Dec 2025
Recognition
18 Nov 2025
Partnership
Halozyme
Coming soon